Closed Solicitation · DEPT OF DEFENSE

    FROZEN BLOOD

    Sol. 12263311PresolicitationFPO, VA
    Closed
    STATUS
    Closed
    closed Nov 18, 2025
    POSTED
    Nov 17, 2025
    Publication date
    NAICS CODE
    339112
    Primary industry classification
    PSC CODE
    6550
    Product & service classification

    AI Summary

    The Defense Health Agency seeks to procure CPDA triple blood bags and Glycerolyte 57% Solution from Fenwal, Inc. for use with existing medical equipment. This sole source procurement is FDA approved and requires timely delivery from December 2025 to September 2026. Interested vendors must submit capability statements by November 18, 2025.

    Contract details

    Solicitation No.
    12263311
    Notice Type
    Presolicitation
    Posted Date
    November 17, 2025
    Response Deadline
    November 18, 2025
    NAICS Code
    339112AI guide
    PSC / Class Code
    6550
    Issuing Office
    DEFENSE HEALTH AGENCY
    Primary Contact
    Gerrie Johnson
    City
    FPO
    State
    VA
    ZIP Code
    22042
    AI Product/Service
    product

    Description

    The Defense Health Agency Contracting Activity (DHACA) Healthcare Contracting Division- Southeast (HCD-Southeast) intends to negotiate on a sole source basis IAW FAR 13.501(a), Only One Responsible Source. The proposed source is Fenwal, Inc., a Fresenius Kabi Company (Fenwal) of Three Corporate Drive, Lake Zurich, IL 60047.

    The Naval Medical Center Camp Lejeune (NMCCL), NC Blood Donor Center has a requirement for CPDA triple blood bags and Glycerolyte 57% Solution. The requested items shall be configured and validated for use with the Haemonetic ACP 215s that NMCCL currently owns. The items shall be Food and Drug Administration (FDA), which is approved for patient care. The requested supplies shall be configured and validated for use with the AMICUS™ Separator Collection System that NMCCL currently owns. The supplies shall be delivered timely, and products shall be free of defects in accordance with federal and industry standards per Food and Drug Administration (FDA) regulations. The supplies shall be provided for a delivery period from 01 December 2025 – 30 September 2026.

    There are no set-aside restrictions for this requirement.  The intended procurement will be classified under North America Industry Classification System (NAICS) 339112.  This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement.  However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product.  All capability statements received by the closing date of this synopsis will be considered by the Government.  A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government.  Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

    If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Gerrie Johnson at Gerrie.m.johnson.civ@health.mil .  Closing date for challenges is no later than 4:00 PM ET on 18 November 2025.  No phone calls will be accepted.

    Key dates

    1. November 17, 2025Posted Date
    2. November 18, 2025Proposals / Responses Due

    AI search tags

    Frequently asked questions

    FROZEN BLOOD is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.